These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 9481480)

  • 1. Mibefradil (Ro 40-5967) blocks multiple types of voltage-gated calcium channels in cultured rat spinal motoneurones.
    Viana F; Van den Bosch L; Missiaen L; Vandenberghe W; Droogmans G; Nilius B; Robberecht W
    Cell Calcium; 1997 Oct; 22(4):299-311. PubMed ID: 9481480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Voltage-dependent blockade of diverse types of voltage-gated Ca2+ channels expressed in Xenopus oocytes by the Ca2+ channel antagonist mibefradil (Ro 40-5967).
    Bezprozvanny I; Tsien RW
    Mol Pharmacol; 1995 Sep; 48(3):540-9. PubMed ID: 7565636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ca2+ channel actions of the non-dihydropyridine Ca2+ channel antagonist Ro 40-5967 in vascular muscle cells cultured from dog coronary and saphenous arteries.
    Bian K; Hermsmeyer K
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Aug; 348(2):191-6. PubMed ID: 7694155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective inhibition of T-type Ca2+ channels by Ro 40-5967.
    Mishra SK; Hermsmeyer K
    Circ Res; 1994 Jul; 75(1):144-8. PubMed ID: 8013072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ca2+ currents in central insect neurons: electrophysiological and pharmacological properties.
    Wicher D; Penzlin H
    J Neurophysiol; 1997 Jan; 77(1):186-99. PubMed ID: 9120560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mibefradil (Ro 40-5967) inhibits several Ca2+ and K+ currents in human fusion-competent myoblasts.
    Liu JH; Bijlenga P; Occhiodoro T; Fischer-Lougheed J; Bader CR; Bernheim L
    Br J Pharmacol; 1999 Jan; 126(1):245-50. PubMed ID: 10051142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T- and L-type Ca2+-channel antagonists reduce contractility in guinea pig cardiac myocytes.
    Hoischen S; Brixius K; Schwinger RH
    J Cardiovasc Pharmacol; 1998 Aug; 32(2):323-30. PubMed ID: 9700997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ca2+ and Na+ permeability of high-threshold Ca2+ channels and their voltage-dependent block by Mg2+ ions in chick sensory neurones.
    Carbone E; Lux HD; Carabelli V; Aicardi G; Zucker H
    J Physiol; 1997 Oct; 504 ( Pt 1)(Pt 1):1-15. PubMed ID: 9350613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mibefradil, A T-type calcium channel antagonist in Y1 cells.
    Esneu M; Gallo-Payet N; Payet MD
    Endocr Res; 1998; 24(3-4):449-54. PubMed ID: 9888524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurotensin and substance P inhibit low- and high-voltage-activated Ca2+ channels in cultured newborn rat nucleus basalis neurons.
    Margeta-Mitrovic M; Grigg JJ; Koyano K; Nakajima Y; Nakajima S
    J Neurophysiol; 1997 Sep; 78(3):1341-52. PubMed ID: 9310425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of voltage- and use-dependent block of class A Ca2+ channels by mibefradil.
    Aczél S; Kurka B; Hering S
    Br J Pharmacol; 1998 Oct; 125(3):447-54. PubMed ID: 9806326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of membrane depolarization and T-type Ca2+ channels in angiotensin II and K+ stimulated aldosterone secretion.
    Lotshaw DP
    Mol Cell Endocrinol; 2001 Apr; 175(1-2):157-71. PubMed ID: 11325526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure and functional characterization of a novel human low-voltage activated calcium channel.
    Williams ME; Washburn MS; Hans M; Urrutia A; Brust PF; Prodanovich P; Harpold MM; Stauderman KA
    J Neurochem; 1999 Feb; 72(2):791-9. PubMed ID: 9930755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrasting biophysical and pharmacological properties of T-type and R-type calcium channels.
    Randall AD; Tsien RW
    Neuropharmacology; 1997 Jul; 36(7):879-93. PubMed ID: 9257934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Ca(++)-channel blocker Ro 40-5967 blocks differently T-type and L-type Ca++ channels.
    Mehrke G; Zong XG; Flockerzi V; Hofmann F
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1483-8. PubMed ID: 7996461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition by mibefradil, a novel calcium channel antagonist, of Ca(2+)- and volume-activated Cl- channels in macrovascular endothelial cells.
    Nilius B; Prenen J; Kamouchi M; Viana F; Voets T; Droogmans G
    Br J Pharmacol; 1997 Jun; 121(3):547-55. PubMed ID: 9179399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of mibefradil on voltage-dependent gating and kinetics of T-type Ca(2+) channels in cortisol-secreting cells.
    Gomora JC; Xu L; Enyeart JA; Enyeart JJ
    J Pharmacol Exp Ther; 2000 Jan; 292(1):96-103. PubMed ID: 10604935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential-dependent inhibition of cardiac Ca2+ inward currents by Ro 40-5967 and verapamil: relation to negative inotropy.
    Fang LM; Osterrieder W
    Eur J Pharmacol; 1991 Apr; 196(2):205-7. PubMed ID: 1651875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mibefradil inhibition of T-type calcium channels in cerebellar purkinje neurons.
    McDonough SI; Bean BP
    Mol Pharmacol; 1998 Dec; 54(6):1080-7. PubMed ID: 9855637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular T-type calcium channels: physiological and pharmacological significance.
    Triggle DJ
    J Hypertens Suppl; 1997 Dec; 15(5):S9-15. PubMed ID: 9481611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.